Navigation Links
UCSD discovery may help extend life of natural pesticide

A team led by biologists at the University of California, San Diego has discovered a molecule in roundworms that makes them susceptible to Bacillus thuringiensis toxin, or Bt toxin--a pesticide produced by bacteria and widely used by organic farmers and in genetically engineered crops to ward off insect pests.

Their findings should facilitate the design and use of Bt toxins to prevent insects, which the researchers believe also possess the molecule, from developing resistance to Bt, extending the life of this natural pesticide.

The study, published February 11 in the journal Science, details the structure of a molecule to which Bt attaches, or "binds," in the lining of the intestines of insects and roundworms. The molecule is a glycolipid--a lipid attached to a tree-like arrangement of sugars. Because changes in the sugars impact Bt's ability to bind, the researchers believe that their discovery will make it possible to develop better pesticides and lead to new treatments for parasitic infections that affect close to two billion people worldwide.

"Our previous findings with the roundworm C. elegans strongly suggested that specific sugar structures are likely critical for Bt toxin susceptibility," said Joel Griffitts, the first author on the paper and a former graduate student with UCSD biology professor Raffi Aroian. "This latest paper demonstrates what these sugars actually do. They provide a receptor for the toxin that allows the toxin to recognize its "victim"--a roundworm or an insect. This paper also brings us from the conceptual realm to the chemical nature of these sugar structures--how their atoms are arranged, and how the toxin binds to them."

"Bt toxin, which is produced by a soil bacterium, is toxic to insects and roundworms, but not to vertebrates, which accounts for its popularity as a pesticide," explained Aroian, who led the team. "But the development of insect resistance to Bt is a major threat to its long term use. Our findings make it possible to understand resistance at the molecular level and should improve resistance management."

In collaboration with Paul Cremer and Tinglu Yang, coauthors on the paper and chemists at Texas A&M University, Griffitts and Aroian found that Bt toxin directly binds glycolipids. However, in each of the four Bt resistant mutants tested--bre-2, bre-3, bre-4 and bre-5--the researchers found that there was either zero or dramatically reduced binding of glycolipids to Bt toxin. They concluded that the defective sugar structure of the glycolipid receptor in each of the mutants prevents Bt from binding.

Other members of the research team, coauthors Stuart Haslam and Anne Dell, biologists at Imperial College London; Barbara Mulloy, a biochemist at the Laboratory for Molecular Structure, National Institute for Biological Standards and Control in Hertfordshire, England; and Howard Morris, a biochemist at the M-SCAN Mass Spectrometry Research and Training Centre in Berkshire England, determined the chemical structure of the normal glycolipid receptor that binds Bt toxin.

Elements of this structure are found in both insects and nematodes, but are not found in vertebrates at all, which may be one reason these proteins are safe to vertebrates. This work furthermore opens up the possibility of using Bt toxins against roundworms that parasitize humans.

"These parasites infect nearly one-third of the human population and pose a significant health problem in developing countries," said Aroian. "Perhaps one-day vertebrate-safe Bt toxins could be used as human therapies against these parasites."

Griffitts and Aroian credit the flexibility of the roundworm C. elegans as an experimental system, particularly the ease of manipulating it genetically, in making it possible to find and characterize the structure of the long sought-after Bt receptor. However, their results apply to insects as well. Michael Adang and Stephan Garczyn ski, coauthors and entomologists at the University of Georgia, showed that the glycolipid receptor is present in the tobacco hornworm, an insect pest that is susceptible to Bt toxins used commercially in plants.

"It will now be possible to monitor insect populations near fields where Bt is used and catch insect resistance in its early stages by looking for changes in glycolipids," said Aroian. "If changes are detected, switching to another pesticide, perhaps even another variety of Bt that works through a different mechanism, could prevent the resistance genes from becoming widespread."

According to the researchers, prior work indicates that there are other receptors that also contribute to Bt resistance. Combining pesticides that work through different receptors or designing pesticides that can work through more than one receptor type could thwart the development of resistance.

"This paper presents an intriguing question," said Griffitts. "In light of findings by insect biologists that certain proteins function as important Bt toxin receptors in some cases, how might glycolipid and protein receptors cooperate to engage this intoxication program? If the field can figure this out, it might allow for the engineering of toxins that can utilize either type of receptor alternatively, such that host resistance would require the mutation of both receptor types. This means that resistance would be exponentially less probable."


'"/>

Source:University of California - San Diego


Related biology news :

1. Protein discovery could unlock the secret to better TB treatment
2. Purdue proves concept of using nano-materials for drug discovery
3. Leprosy microbes lead scientists to immune discovery
4. Biochemists report discovery of structure of major piece of telomerase; implications for cancer
5. Researchers make surprise discovery that some neurons can transmit three signals at once
6. Important discovery about second most fatal cancer
7. Harmless virus may hold key to more effective HIV drug discovery
8. Fundamental discovery -- Bone fracture
9. Genetic discovery could lead to drought-resistant plants
10. Gene discovery sheds light on causes of rare disease, cancer
11. Biota makes major antiviral discovery
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/16/2016)... DUBLIN , Dec 16, 2016 Research ... Access System Market - Global Forecast to 2021" report to ... ... projected to grow at a CAGR of 14.06% from 2016 to ... 2016, and is projected to reach 854.8 Million by 2021. The ...
(Date:12/15/2016)... and BADEN-BADEN, Germany , December 15, 2016 ... financial services provider, today announced an agreement with NuData Security, ... to join forces. The partnership will enable clients to focus ... compliance with local data protection regulation. ... In order to provide a ...
(Date:12/15/2016)... DUBLIN , Dec 15, 2016 ... Research and Markets has announced ... to their offering. The report forecasts the global military ... 2016-2020. The report has been prepared based on an ... market landscape and its growth prospects over the coming years. The report ...
Breaking Biology News(10 mins):
(Date:1/23/2017)... , Jan. 23, 2017  Alkahest Inc. ... treatments for neurodegenerative diseases and other age-related conditions, ... the company as Chief Medical Officer. In this ... clinical development activities at Alkahest and serve on ... most recently served as Executive Director at Dynavax, ...
(Date:1/23/2017)... ... January 23, 2017 , ... CallTower is proud to announce ... of the Year Award winner for 2017. , For three consecutive years, CallTower ... In 2016, CallTower was awarded with the hosted VoIP Excellence award and in 2015, ...
(Date:1/21/2017)... ... January 20, 2017 , ... Nipro Corporation (Osaka, Japan) and Transonic Systems Inc. ... will receive exclusive marketing and sales rights for all non-OEM Transonic products in Japan. ... in Japan, the new Nipro - Transonic JV is a natural next step to ...
(Date:1/21/2017)... 2017 Interpace Diagnostics Group, Inc. (NASDAQ: ... clinically useful molecular diagnostic tests and pathology services, ... securities purchase agreement with three  institutional investors to ... stock in a registered direct offering.  In a ... sell to the same investors warrants to purchase ...
Breaking Biology Technology: